Eyenuk, Inc. Founded by Kaushal Solanki, Eyenuk harnesses the power of AI to analyze retinal images, driven by Solanki's personal experience and a passion for addressing the shortage of qualified professionals in the field. Their mission is to accelerate the world's transition to predictive and preventative healthcare with innovative, AI-driven diagnostic solutions.

Eyenuk's first commercial product, EyeArt, utilizes their proprietary platform for autonomous disease detection with exceptional clinical performance. They offer screenings for life- and vision-threatening diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer's disease. Eyenuk's products and services aim to ensure timely diagnoses and improve patient outcomes.

Led by a dynamic management team, including Founder & CEO Kaushal Solanki and Chief Commercial Officer Paul Praino, Eyenuk combines expertise in artificial intelligence, healthcare, research and development, engineering, and product management to revolutionize the field of eye screening. With a focus on predictive and preventative care, Eyenuk is committed to screening every eye in the world